loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

Approved Drug Products containing Tox21_300532 listed with Health Canada. Original Data : Health Canada Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DECHRA LTD (3)

02 JAMP PHARMA CORPORATION (2)

03 MARCAN PHARMACEUTICALS INC (2)

04 PALADIN LABS INC. (2)

filter

01 METHIMAZOLE (9)

filter

01 TABLET (9)

filter

01 FELIMAZOLE 1.25 MG (1)

02 FELIMAZOLE 2.5MG (1)

03 FELIMAZOLE 5MG (1)

04 JAMP METHIMAZOLE (2)

05 MAR-METHIMAZOLE (2)

06 TAPAZOLE (2)

URL Supplier Web Content
TABLET
2.5MG
FELIMAZOLE 2.5MG
2332655
100
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
5MG
FELIMAZOLE 5MG
2332663
100
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
1.25MG
FELIMAZOLE 1.25 MG
2411512
100
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
5MG
JAMP METHIMAZOLE
2490625
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
10MG
JAMP METHIMAZOLE
2490633
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
5MG
MAR-METHIMAZOLE
2480107
100
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
10MG
MAR-METHIMAZOLE
2480115
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PALADIN LABS INC.

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
TABLET
5MG
TAPAZOLE
15741
100
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PALADIN LABS INC.

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
TABLET
10MG
TAPAZOLE
2296039
100
Prescription
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY